CIK 0001551306 · Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 272220139
- Phone
- 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,646,663
- in 9 filings, $22.0M under 10b5-1 plans
Net −$22,646,663. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | Anevski Peter CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +185,134 | $0.91 | $168K | 947,602 |
| 2026-11-10 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −120,213 | $35.61 | $4.3M | 827,389 |
| 2026-11-10 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −64,921 | $36.29 | $2.4M | 762,468 |
| 2026-11-10 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −33,437 | $35.61 | $1.2M | 729,031 |
| 2026-11-10 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −18,059 | $36.29 | $655K | 710,972 |
| 2026-11-10 | Anevski Peter CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −185,134 | 157,369 | ||
| 2026-11-10 | Schlanger David J Executive Chairman | Option exercise 10b5-1 | +35,392 | $0.91 | $32K | 273,854 |
| 2026-11-10 | Schlanger David J Executive Chairman | Sale 10b5-1 | −35,392 | $35.36 | $1.3M | 238,462 |
| 2026-11-10 | Schlanger David J Executive Chairman | Option exercise · Stock Option (Right to Buy) 10b5-1 | −35,392 | 32,229 | ||
| 2026-11-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +126,204 | $0.91 | $115K | 923,776 |
| 2026-11-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −126,204 | $35.73 | $4.5M | 797,572 |
| 2026-11-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −35,104 | $35.73 | $1.3M | 762,468 |
| 2026-11-09 | Anevski Peter CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −126,204 | 342,503 | ||
| 2026-11-09 | Schlanger David J Executive Chairman | Option exercise 10b5-1 | +161,208 | $0.91 | $147K | 399,670 |
| 2026-11-09 | Schlanger David J Executive Chairman | Sale 10b5-1 | −161,208 | $35.73 | $5.8M | 238,462 |
| 2026-11-09 | Schlanger David J Executive Chairman | Option exercise · Stock Option (Right to Buy) 10b5-1 | −161,208 | 67,620 | ||
| 2026-11-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +3,400 | $0.91 | $3K | 809,511 |
| 2026-11-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −3,400 | $35.23 | $120K | 806,111 |
| 2026-11-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −8,539 | $35.09 | $300K | 797,572 |
| 2026-11-05 | Anevski Peter CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,400 | 468,707 |
Page 1 of 11 · 207 trades